Benzinga · Jul 31, 2026
Barclays Maintains Equal-Weight on Hawkins, Lowers Price Target to $142
Barclays analyst William Grippin maintains Hawkins (NASDAQ:HWKN) with a Equal-Weight and lowers the price target from $170 to $142.
NASDAQ · HWKN
Basic Materials · Chemicals - Specialty
$131.05
Up+$3.00 (+2.34%)
Updated Aug 15, 2026, 5:26 PM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
HWKN closed at $131.05 after 21 trading sessions, down 9.25% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $127.52 | $131.565 | $127.40 | $131.05 | 93.22K |
| Aug 13, 2026 | $130.28 | $132.44 | $128.04 | $128.05 | 85.65K |
| Aug 12, 2026 | $131.06 | $132.00 | $127.83 | $129.47 | 103.49K |
| Aug 11, 2026 | $131.75 | $133.49 | $128.07 | $129.66 | 130.32K |
| Aug 10, 2026 | $129.78 | $132.5014 | $128.925 | $130.66 | 113.89K |
| Aug 7, 2026 | $130.14 | $131.2699 | $127.88 | $129.91 | 131.12K |
| Aug 6, 2026 | $135.95 | $137.23 | $129.46 | $130.03 | 140.69K |
| Aug 5, 2026 | $133.06 | $136.00 | $133.06 | $135.29 | 136.38K |
| Aug 4, 2026 | $132.08 | $135.05 | $132.08 | $133.69 | 170.14K |
| Aug 3, 2026 | $128.74 | $133.025 | $128.74 | $132.08 | 137.85K |
| Jul 31, 2026 | $127.08 | $128.13 | $119.02 | $128.03 | 300.05K |
| Jul 30, 2026 | $136.00 | $136.86 | $126.075 | $129.22 | 324.08K |
| Jul 29, 2026 | $142.19 | $142.26 | $137.83 | $138.60 | 135.39K |
| Jul 28, 2026 | $142.04 | $144.46 | $141.37 | $143.02 | 129.62K |
| Jul 27, 2026 | $139.76 | $141.98 | $136.88 | $140.39 | 202.45K |
| Jul 24, 2026 | $140.99 | $141.74 | $135.03 | $139.03 | 255.92K |
| Jul 23, 2026 | $141.63 | $144.98 | $138.16 | $139.33 | 314.34K |
| Jul 22, 2026 | $144.10 | $147.285 | $143.05 | $143.17 | 139.82K |
| Jul 21, 2026 | $145.30 | $147.98 | $143.73 | $143.84 | 165.24K |
| Jul 20, 2026 | $144.51 | $146.99 | $142.48 | $145.29 | 110.49K |
| Jul 17, 2026 | $142.09 | $148.41 | $140.25 | $144.41 | 141.61K |
The latest Smart Investors Daily articles mentioning HWKN.
HWKN research
Company profile and research snapshot.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 3, 2026 | BWS Financial | Buy | — |
| Jul 31, 2026 | Barclays | Equal-Weight | — |
| Jun 30, 2026 | Barclays | Equal-Weight | — |
| Mar 23, 2026 | BWS Financial | Buy | — |
| Jan 29, 2026 | BWS Financial | Buy | — |
No generated briefing is available yet.
Benzinga · Jul 31, 2026
Barclays analyst William Grippin maintains Hawkins (NASDAQ:HWKN) with a Equal-Weight and lowers the price target from $170 to $142.
Yahoo · Jul 29, 2026
Hawkins (HWKN) delivered earnings and revenue surprises of -4.26% and +0.72%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ChartMill · Jul 29, 2026
Hawkins Inc Q1 EPS missed estimates at $1.35 vs $1.42, revenue in line at $315.68M. Stock flat after hours; board raised dividend 5% to $0.20.
Yahoo · Jul 29, 2026
ROSEVILLE, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027. First Quarter Fiscal Year 2027 Highlights: (All comparisons are to the first quarter of fiscal 2026 unless otherwise noted.) Record first quarter revenue of $315.7 million, with growth of 8%, driven by increased sales across all segments, including Water Treatment segment growth of 6%, Food & Health Sciences segment g
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HWKN.